Israel's Teva Pharmaceuticals Seeks Buyer for Its Medis Unit to Raise Cash

Bloomberg News says sale of unit could fetch up to $1 billion as the pharma giant struggles with debt and low profits

TheMarker
Reuters
Send in e-mailSend in e-mail
A building belonging to Teva Pharmaceutical Industries, the world's biggest generic drugmaker and Israel's largest company, in Jerusalem, February 8, 2017.
A building belonging to Teva Pharmaceutical Industries, the world's biggest generic drugmaker and Israel's largest company, in Jerusalem, February 8, 2017. Credit: Ronen Zvulun/Reuters

Comments